Alessandro Smeraldi, MD, is chair for the Northeast Regional Cancer Institute’s 22nd Annual CASUAL (Colon Cancer Awareness Saves Unlimited Adult Lives) Day for a second year.
Instylla, Inc., a privately held clinical-stage company developing solutions for peripheral vascular embolotherapy, has announced the FDA 510(k) clearance of the Tembotm Embolic System. The Tembo ...
Background Establishing intravenous access is often vital in an acute hospital setting but can be difficult. Ultrasound-guided cannulation increases success rates in prospective studies. However, ...
( MENAFN - EIN Presswire) The Interventional Cardiovascular Devices market is projected to expand at a CAGR of 4.66%, reaching a market size of USD 69.1 billion by 2032 ...